Designer benzodiazepines versus prescription benzodiazepines: can structural relation predict the next step?

References

• Alván G, Odar-Cederlöf I. 1978. The pharmacokinetic profile of oxazepam. Acta Psychiatr Scand Suppl. 58(S274):47–55.
   Google Scholar
• Anonymous. 2017. Fonazepam: first thoughts:research chemicals. [accessed 2020 February 10]. https://www.reddit.com/r/researchchemicals/comments/5gciof/fonazepam_first_thoughts/.
   Google Scholar
• Aronson JK, editor. 2016. Flunitrazepam. In: Meyler’s side effects of drugs. Amsterdam (The Netherlands): Elsevier; p. 364.
   Google Scholar
• Babbini M, Gaiardi M, Bartoletti M. 1979. Anxiolytic versus sedative properties in the benzodiazepines series: differencies in structure-activity relationships. Life Sci. 25(1):15–22.
   PubMed Web of Science ®Google Scholar
• Balkhi SE, Monchaud C, Herault F, Géniaux H, Saint-Marcoux F. 2020. Designer benzodiazepines’ pharmacological effects and potencies: how to find the information. J Psychopharmacol. 34(9):1021–1029.
   PubMed Web of Science ®Google Scholar
• Bareggi SR, Pirola R, Potvin P, Devis G. 1995. Effects of liver disease on the pharmacokinetics of intravenous and oral chlordesmethyldiazepam. Eur J Clin Pharmacol. 48(3–4):265–268.
   PubMed Web of Science ®Google Scholar
• Bassan DM, Erdmann F, Krüll R. 2011. Quantitative determination of 43 common drugs and drugs of abuse in human serum by HPLC-MS/MS. Anal Bioanal Chem. 400(1):43–50.
   PubMed Web of Science ®Google Scholar
• Bertol E, Vaiano F, Borsotti M, Quercioli M, Mari F. 2013. Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: results of a national proficiency test. J Anal Toxicol. 37(9):659–664.
   PubMed Web of Science ®Google Scholar
• Betlazar C, Middleton RJ, Banati R, Liu G-J. 2020. The translocator protein (TSPO) in mitochondrial bioenergetics and immune processes. Cells. 9(2):512.
   PubMed Web of Science ®Google Scholar
• Bévalot F, Cartiser N, Bottinelli C, Fanton L, Guitton J. 2015. Correlation of bile and vitreous humor concentrations with blood drug concentrations for forensic interpretation: a comparative study between animal experimental and human postmortem data. Forensic Toxicol. 33(1):131–140.
   Web of Science ®Google Scholar
• Bischoff K. 2018. Toxicity of drugs of abuse. In: Veterinary toxicology: basic and clinical principles. 3rd ed. Amsterdam (The Netherlands): Elsevier; p. 385–408.
   Google Scholar
• Bogusz MJ, Maier RD, Krüger KD, Früchtnicht W. 1998. Determination of flunitrazepam and its metabolites in blood by high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Chromatogr B Biomed Appl. 713(2):361–369.
   Web of Science ®Google Scholar
• Calcaterra NE, Barrow JC. 2014. Classics in chemical neuroscience: diazepam (valium). ACS Chem Neurosci. 5(4):253–260.
   PubMed Web of Science ®Google Scholar
• Castle JW, Butzbach DM, Walker GS, Lenehan CE, Reith F, Kirkbride KP. 2017. Microbial impacts in postmortem toxicology. In David O. Carter, Jeffery K. Tomberlin, M. Eric Benbow, Jessica L. Metcalf, editors. Forensic Microbiology; p. 212–244.
   Google Scholar
• Chaytor A. 2007. Diazepam. In: xPharm: the comprehensive pharmacology reference. Amsterdam (The Netherlands): Elsevier Inc.; p. 1–7.
   Google Scholar
• Clayton T, Chen JL, Ernst M, Richter L, Cromer BA, Morton CJ, Ng H, Kaczorowski CC, Helmstetter FJ, Furtmüller R, et al. 2007. An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: correlation with comparative models. Curr Med Chem. 14(26):2755–2775.
   PubMed Web of Science ®Google Scholar
• Coller JK, Somogyi AA, Bochner F. 1998. Quantification of flunitrazepam>’s oxidative metabolites, 3-hydroxyflunitrazepam and desmethylflunitrazepam, in hepatic microsomal incubations by high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 719(1–2):87–92.
   Google Scholar
• Cornett EM, Novitch MB, Brunk AJ, Davidson KS, Menard BL, Urman RD, Kaye AD. 2018. New benzodiazepines for sedation. Best Pract Res Clin Anaesthesiol. 32(2):149–164.
   PubMed Web of Science ®Google Scholar
• Davey Z, Schifano F, Corazza O, Deluca P. 2012. E-Psychonauts: conducting research in online drug forum communities. J Ment Health. 21(4):386–394.
   PubMed Web of Science ®Google Scholar
• Degouffe M, Drost M. 1995. A comparison of drug concentrations in postmortem cardiac and peripheral blood in 320 cases. J Can Soc Forensic Sci. 28(2):113–121.
   Google Scholar
• Degreef M, Vits L, Berry EM, Maudens KEK, Centre T. 2020. Quantification of 54 benzodiazepines & Z-drugs, including 20 designer ones, in plasma. J. Anal. Toxicol. 1–22.
   PubMedGoogle Scholar
• Dispersive TULS. 2017. Ultrasound-assisted low-density solvent dispersive liquid-liquid microextraction for the determination of 4 designer benzodiazepines in urine samples by gas chromatography-triple quadrupole mass spectrometry. J Chromatogr B. 1053:9–15.
   PubMed Web of Science ®Google Scholar
• Drummer OH. 2008. Postmortem toxicological redistribution. In: Rutty GN, editor. Essentials of autopsy practice: topical developments, trends and advances. London (UK): Springer.
   Google Scholar
• El Balkhi S, Chaslot M, Picard N, Dulaurent S, Delage M, Mathieu O, Saint-Marcoux F. 2017. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer. Int J Legal Med. 131(4):979–988.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. 2014. European Drug Report 2014: trends and developments [Internet]. Lisbon (Portugal): EMCDDA; [accessed 2021 February 6]. https://www.emcdda.europa.eu/publications/edr/trends-developments/2016_en
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. 2018. The misuse of benzodiazepines among high-risk opioid users in Europe [Internet]. Lisbon (Portugal): EMCDDA; [accessed 2021 February 6]. https://www.emcdda.europa.eu/publications/pods/benzodiazepines_en
   Google Scholar
• FDA. 2016. Roche Pharmaceutical Companies. Valium (Diazepam) [package insert]. U.S. Food and Drug Administration website. [accessed 2021 February 9]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/013263s094lbl.pdf.
   Google Scholar
• Ferner RE. 2008. Post-mortem clinical pharmacology. Br J Clin Pharmacol. 66(4):430–443.
   PubMed Web of Science ®Google Scholar
• File SE, Pellow S. 1985. The anxiogenic action of RO 5-4864 in the social interaction test: effect of chlordiazepoxide, RO 15-1788 and CGS 8216. Naunyn Schmiedebergs Arch Pharmacol. 328(3):225–228.
   PubMed Web of Science ®Google Scholar
• Fiorentin TR, Logan BK. 2018. Toxicological findings in 1000 cases of suspected drug facilitated sexual assault in the United States. J Forensic Leg Med. 61:56–64.
   PubMed Web of Science ®Google Scholar
• Gavioli EC, Silveira DF, Bressan E, Ferrara P, Coimbra FR, De LT. 2003. Antidepressant-like effect of Ro5-4864, a peripheral-type benzodiazepine receptor ligand, in forced swimming test. Eur J Pharmacol. 471(1):21–26.
   PubMed Web of Science ®Google Scholar
• Goodchild CS. 1993. Gaba receptors and benzodiazepines. Br J Anaesth. 71(1):127–133.
   PubMed Web of Science ®Google Scholar
• Hargrove VM, McCutcheon JR. 2008. Comparison of drug concentrations taken from clamped and unclamped femoral vessels. J Anal Toxicol. 32(8):621–625.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Watanabe K, Suzuki O. 2015. Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms. Forensic Toxicol. 33(1):45–53.
   Web of Science ®Google Scholar
• Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Watanabe K, Suzuki O. 2015. Postmortem distribution of flunitrazepam and its metabolite 7-aminoflunitrazepam in body fluids and solid tissues in an autopsy case: usefulness of bile for their detection. Leg Med. 17(5):394–400.
   PubMed Web of Science ®Google Scholar
• Hastedt M. 2015. Disposition of toxic drugs and chemicals in man, 10th edition. Forensic Sci Med Pathol. 11(1):147–147.
   Google Scholar
• Heide G, Høiseth G, Middelkoop G, Øiestad ÅML. 2020. Blood concentrations of designer benzodiazepines: relation to impairment and findings in forensic cases. J Anal Toxicol. 44(8):905–914.
   PubMed Web of Science ®Google Scholar
• Jones AW, Kugelberg FC, Holmgren A, Ahlner J. 2011. Drug poisoning deaths in Sweden show a predominance of ethanol in mono-intoxications, adverse drug-alcohol interactions and poly-drug use. Forensic Sci Int. 206(1–3):43–51.
   PubMed Web of Science ®Google Scholar
• Katselou M, Papoutsis I, Nikolaou P, Spiliopoulou C, Athanaselis S. 2017. Metabolites replace the parent drug in the drug arena. The cases of fonazepam and nifoxipam. Forensic Toxicol. 35(1):1–10.
   PubMed Web of Science ®Google Scholar
• Kennedy MC. 2010. Post-mortem drug concentrations. Intern Med J. 40(3):183–187.
   PubMed Web of Science ®Google Scholar
• Laloup M, Ramirez Fernandez MDM, Wood M, Maes V, De Boeck G, Vanbeckevoort Y, Samyn N. 2007. Detection of diazepam in urine, hair and preserved oral fluid samples with LC-MS-MS after single and repeated administration of Myolastan and Valium®. Anal Bioanal Chem. 388(7):1545–1556.
   PubMed Web of Science ®Google Scholar
• Lann MA, Molina DK. 2009. A fatal case of benzodiazepine withdrawal. Am J Forensic Med Pathol. 30(2):177–179.
   PubMed Web of Science ®Google Scholar
• Lehmann S, Sczyslo A, Froch-Cortis J, Rothschild MA, Thevis M, Andresen-Streichert H, Mercer-Chalmers-Bender K. 2019. Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine. Forensic Sci Int. 303:1–11.
   Web of Science ®Google Scholar
• Lemaire E, Schmidt C, Denooz R, Charlier C, Boxho P. 2016a. Postmortem concentration and redistribution of diazepam, methadone, and morphine with subclavian and femoral vein dissection/clamping. J Forensic Sci. 61(6):1596–1603.
   PubMed Web of Science ®Google Scholar
• Lemaire E, Schmidt C, Denooz R, Charlier C, Boxho P. 2016b. Popliteal vein blood sampling and the postmortem redistribution of diazepam, methadone, and morphine. J Forensic Sci. 61(4):1017–1028.
   PubMed Web of Science ®Google Scholar
• Lemaire E, Schmidt C, Dubois N, Denooz R, Charlier C, Boxho P. 2017. Site-, technique-, and time-related aspects of the postmortem redistribution of diazepam, methadone, morphine, and their metabolites: interest of popliteal vein blood sampling. J Forensic Sci. 62(6):1559–1574.
   PubMed Web of Science ®Google Scholar
• Li Y, Ning J, Wang Y, Wang C, Sun C, Huo X, Yu Z, Feng L, Zhang B, Tian X, et al. 2018. Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects. Toxicol Lett. 294:27–36.
   PubMed Web of Science ®Google Scholar
• Luk S, Atayee RS, Ma JD, Best BM. 2014. Urinary diazepam metabolite distribution in a chronic pain population. J Anal Toxicol. 38(3):135–142.
   PubMed Web of Science ®Google Scholar
• Maddalena DJ, Johnston GAR. 1995. Prediction of receptor properties and binding affinity of ligands to benzodiazepine/GABAA receptors using artificial neural networks. J Med Chem. 38(4):715–724.
   PubMed Web of Science ®Google Scholar
• Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. 2018. The emergence of new psychoactive substance (NPS) benzodiazepines: a review. Drug Test Anal. 10(1):37–53.
   PubMed Web of Science ®Google Scholar
• Manchester KR, Maskell PD, Waters L. 2018. Experimental versus theoretical log D7.4, pKa and plasma protein binding values for benzodiazepines appearing as new psychoactive substances. Drug Test Anal. 10(8):1258–1269.
   Web of Science ®Google Scholar
• Mandelli M, Tognoni G, Garattini S. 1978. Clinical pharmacokinetics of diazepam. Clin Pharmacokinet. 3(1):72–91.
   PubMed Web of Science ®Google Scholar
• Mattila MA, Larni HM. 1980. Flunitrazepam: a review of its pharmacological properties and therapeutic use. Drugs. 20(5):353–374.
   PubMed Web of Science ®Google Scholar
• Maurer HH, Brandt SD. 2018. New psychoactive substances: pharmacology, clinical, forensic and analytical toxicology. Cham (Switzerland): Springer International Publishing.
   Google Scholar
• Mei V, Concheiro M, Pardi J, Cooper G. 2019. Validation of an LC-MS/MS method for the quantification of 13 designer benzodiazepines in blood. J Anal Toxicol. 43(9):688–695.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Bergstrand MP, Helander A, Beck O. 2016. Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. Anal Bioanal Chem. 408(13):3571–3591.
   PubMed Web of Science ®Google Scholar
• Michel H. 2020. Development of a method for the detection and quantification of various benzodiazepines and Z-Drugs in human blood and qualitative identification in urine samples using liquid chromatography mass spectrometry (LC-MS/MS) chromatog. Williams Honors College, Honors Research Projects.1134.
   Google Scholar
• Moosmann B, Auwärter V. 2018. Designer benzodiazepines: another class of new psychoactive substances. Handb Exper Pharmacol. 252:383–410.
   PubMedGoogle Scholar
• Moosmann B, Bisel P, Auwärter V. 2014. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. Drug Test Anal. 6(7–8):757–763.
   PubMed Web of Science ®Google Scholar
• Moosmann B, Bisel P, Franz F, Huppertz LM, Auwärter V. 2016. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines – an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam. J Mass Spectrom. 51(11):1080–1089.
   PubMed Web of Science ®Google Scholar
• Moosmann B, Bisel P, Westphal F, Wilde M, Kempf J, Angerer V, Auwärter V. 2019. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: an update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864). Drug Test Anal. 11(3):541–549.
   PubMed Web of Science ®Google Scholar
• Namera A, Makita R, Saruwatari T, Hatano A, Shiraishi H, Nagao M. 2012. Acute intoxication caused by overdose of flunitrazepam and triazolam: high concentration of metabolites detected at autopsy examination. Am J Forensic Med Pathol. 33(4):293–296.
   PubMed Web of Science ®Google Scholar
• Nutt DJ, Malizia AL. 2001. New insights into the role of the GABAA-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 179(5):390–396.
   PubMed Web of Science ®Google Scholar
• O’Connor LC, Torrance HJ, McKeown DA. 2016. ELISA detection of phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and delorazepam in blood using Immunalysis® Benzodiazepine kit. J Anal Toxicol. 40(2):159–161.
   PubMed Web of Science ®Google Scholar
• Oelschläger H. 1989. [Chemical and pharmacologic aspects of benzodiazepines]. Schweiz Rundsch Med Prax. 78(27–28):766–772. German.
   PubMedGoogle Scholar
• Orsolini L, Corkery JM, Chiappini S, Guirguis A, Vento A, De Berardis D, Papanti D, Schifano F. 2020. ‘New/designer benzodiazepines’: an analysis of the literature and psychonauts’ trip reports. Curr Neuropharmacol. 18(9):809–837.
   PubMed Web of Science ®Google Scholar
• Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère J-J, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang M-R, et al. 2006. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 27(8):402–409.
   PubMed Web of Science ®Google Scholar
• Paradis S, Leoni V, Caccia C, Berdeaux A, Morin D. 2013. Cardioprotection by the TSPO ligand 4′-chlorodiazepam is associated with inhibition of mitochondrial accumulation of cholesterol at reperfusion. Cardiovasc Res. 98(3):420–427.
   PubMed Web of Science ®Google Scholar
• Partridge E, Trobbiani S, Stockham P, Scott T, Kostakis C. 2018. A validated method for the screening of 320 forensically significant compounds in blood by LC/QTOF, with simultaneous quantification of selected compounds. J Anal Toxicol. 42(4):220–231.
   PubMed Web of Science ®Google Scholar
• Pellow S, File SE. 1984. Behavioural actions of Ro 5-4864: a peripheral-type benzodiazepine? Life Sci. 35(3):229–240.
   PubMed Web of Science ®Google Scholar
• Pettersson Bergstrand M, Beck O, Helander A. 2018. Urine analysis of 28 designer benzodiazepines by liquid chromatography–high-resolution mass spectrometry. Clin Mass Spectrom. 10:25–32.
   Google Scholar
• Pettersson Bergstrand M, Helander A, Hansson T, Beck O. 2017. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays. Drug Test Anal. 9(4):640–645.
   PubMed Web of Science ®Google Scholar
• Pettersson Bergstrand M, Richter LHJ, Maurer HH, Wagmann L, Meyer MR. 2019. In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases. Drug Test Anal. 11(1):45–50.
   PubMed Web of Science ®Google Scholar
• Pettersson M, Helander A, Beck O. 2016. Development and application of a multi-component LC-MS/MS method for determination of designer benzodiazepines in urine. J Chromatogr B Analyt Technol Biomed Life Sci. 1035:104–110.
   PubMed Web of Science ®Google Scholar
• Pok PRP, Haddouche D, Mauras M, Kuhlmann E, Burle J, Salmon T, Berland E, Coiffait PE, Viala A. 2008. Cardiac and peripheral blood similarities in the comparison of nordiazepam and bromazepam blood concentrations. J Anal Toxicol. 32(9):782–786.
   PubMed Web of Science ®Google Scholar
• Prouty RW, Anderson WH. 1990. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci. 35(2):243–270.
   PubMed Web of Science ®Google Scholar
• Robertson MD, Drummer OH. 1995. Postmortem drug metabolism by bacteria. J Forensic Sci. 40(3):89–105.
   Web of Science ®Google Scholar
• Robertson MD, Raymon L. 2001. Rohypnol and other benzodiazepines. In: LeBeau MA, Mozayani A, editors. Drug facilitated sexual assault. London (UK): Academic Press.
   Google Scholar
• Rouini MR, Ardakani YH, Moghaddam KA, Solatani F. 2008. An improved HPLC method for rapid quantitation of diazepam and its major metabolites in human plasma. Talanta. 75(3):671–676.
   PubMed Web of Science ®Google Scholar
• Sakai N, Ishizuka M. 2009. Impact of rat P450 genetic polymorphism on diazepam metabolism. Expert Opin Drug Metab Toxicol. 5(11):1421–1433.
   PubMed Web of Science ®Google Scholar
• Salamone SJ, editor. 2001. Benzodiazepines and GHB: detection and pharmacology. New York (NY): Humana Press.
   Google Scholar
• Sigel E, Schaerer MT, Buhr A, Baur R. 1998. The benzodiazepine binding pocket of recombinant α1β2γ2 γ-aminobutyric acid(A) receptors: relative orientation of ligands and amino acid side chains. Mol Pharmacol. 54(6):1097–1105.
   PubMed Web of Science ®Google Scholar
• Simmons MM, Cupp MJ. 1998. Use and abuse of flunitrazepam. Ann Pharmacother. 32(1):117–119.
   PubMed Web of Science ®Google Scholar
• Skov L, Holm KMD, Johansen SS, Linnet K. 2016. Postmortem brain and blood reference concentrations of alprazolam, bromazepam, chlordiazepoxide, diazepam, and their metabolites and a review of the literature. J Anal Toxicol. 40(7):529–536.
   PubMed Web of Science ®Google Scholar
• Švidrnoch M, Boráňová B, Tomková J, Ondra P, Maier V. 2018. Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis – Tandem mass spectrometry with successive multiple ionic – polymer layer coated capillary. Talanta. 176:69–76.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Sato H, Kasai K. 2017. Flunitrazepam product detected in the stomach of an autopsy case buried under the ground for two years. J Forensic Med. 02(01):2–5.
   Google Scholar
• Tomková J, Švidrnoch M, Maier V, Ondra P. 2017. Analysis of selected designer benzodiazepines by ultra high performance liquid chromatography with high-resolution time-of-flight mass spectrometry and the estimation of their partition coefficients by micellar electrokinetic chromatography. J Sep Sci. 40(9):2037–2044.
   PubMed Web of Science ®Google Scholar
• Tzanavaras PD, Zacharis CK. 2010. Reviews in pharmaceutical and biomedical analysis. Sharjah (UAE): Bentham e Books.
   Google Scholar
• UNODC. 2017. Non-medical use of benzodiazepines: a growing threat to public health? Glob. Smart Updat. 18:12 [Internet]. Vienna (Austria): ONODC. [accessed 2021 February 6]. https://www.unodc.org/documents/scientific/Global_SMART_Update_2017_Vol_18.pdf
   Google Scholar
• Vermeeren A. 2004. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs. 18(5):297–328.
   PubMed Web of Science ®Google Scholar
• Verstraete AG. 2004. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug Monit. 26(2):200–205.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang R, Zhang Y, Liang C, Ye H, Cao F, Rao Y. 2012. Extending the detection window of diazepam by directly analyzing its glucuronide metabolites in human urine using liquid chromatography-tandem mass spectrometry. J Chromatogr A. 1268:29–34.
   PubMed Web of Science ®Google Scholar
• Waters L, Manchester KR, Maskell PD, Haegeman C, Haider S. 2018. The use of a quantitative structure-activity relationship (QSAR) model to predict GABA-A receptor binding of newly emerging benzodiazepines. Sci Justice. 58(3):219–225.
   PubMed Web of Science ®Google Scholar
• Woods JH, Winger G. 1997. Abuse liability of flunitrazepam. J Clin Psychopharmacol. 17(3):1S–57S.
   PubMed Web of Science ®Google Scholar
• Zilg B, Thelander G, Giebe B, Druid H. 2017. Postmortem blood sampling-comparison of drug concentrations at different sample sites. Forensic Sci Int. 278:296–303.
   PubMed Web of Science ®Google Scholar